Boston, Mass. and Indianapolis, Ind. — BioBright and Beckman Coulter announce a strategic partnership to bring enhanced technical support capabilities to instruments. BioBright’s DarwinSync platform gives Beckman Coulter access to a large amount of precise data about deployed instrument logs, enabling faster troubleshooting, reduced equipment downtime, and predictive analytics. Beckman Coulter will deploy BioBright’s DarwinSync platform to multiple […]

Vancouver, Canada – Aspect Biosystems, a privately held biotechnology company focused on commercializing cutting-edge bioprinting technologies, is pleased to announce a new collaboration to develop human liver tissue with JSR Corporation, a leading materials supplier in a variety of technology driven markets.Through this collaboration, Aspect’s proprietary Lab-on-a-Printer™ 3D bioprinting platform and JSR’s advanced materials technology will […]

New license agreements for CRISPR technology from Broad Institute and ERS Genomics extend industry-leading genome editing capabilities CARLSBAD, Calif. — Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing intellectual property (IP) portfolio. Under the terms of […]

BALTIMORE — PathSensors and Ensensor Japan have entered into a partnership to bring novel pathogen detection devices to markets in Japan. Ensensor is a bio-detection company created in joint venture with S.T. Japan, a well-known organization that specializes in selling products such as spectra databases, microscopy accessories, and analytical instruments. The company has become a distributor of PathSensors’ CANARY […]

CE-marked workflow enables efficient, high-throughput screening for tuberculosis control efforts in Europe and other markets; introduction in United States expected in 2019 and China in 2020 Hilden, Germany, and Saluggia, Italy – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE Italy Mid Cap: DIA) today announced the introduction of an automated, CE-marked workflow […]

Cambridge, United Kingdom – Congenica, the global diagnostic decision support platform provider, today announced it has entered into an agreement with a new strategic partner Digital China Health Technologies Cooperation Limited (DCHealth), further extending Congenica’s commitment to the Chinese market. The new partnership will see Congenica develop a version of its Sapientia™ platform designed to enable clinicians and […]

QIAGEN to launch two Sample to Insight systems in Europe and other markets, NeuMoDx to commercialize in the U.S. / Initial assay menu for infectious diseases and LDTs Hilden, Germany, and Ann Arbor, Michigan – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx Molecular, Inc. today announced a strategic partnership to commercialize two new […]

BEIJING — Genecast Biotechnology Co. Ltd. (Genecast) announced it has just reached strategic partnership agreement with the global leader in DNA sequencing and array-based technologies, Illumina. Genecast will seek to advance cancer diagnosis using Illumina’s next-generation sequencing (NGS) technology. Both companies are at the forefront of their fields – Illumina in gene sequencing and Genecast in […]

-Streamlining the Gene Testing Processes to Standardize the Testing- Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu), Toppan Printing Co., Ltd. (HQ: Tokyo, Japan; President & Representative Director: Shingo Kaneko) and RIKEN GENESIS Co., Ltd. (HQ: Tokyo, Japan; President & CEO; Naoto Kondo) have jointly developed the LW-100 Gene Measurement Analyzer (research use […]